AllianceBernstein
XPH icon

AllianceBernstein’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

AllianceBernstein’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-6,888
Closed -$322K – 3653
2014
Q1 		$322K Buy
+6,888
New +$325K ﹤0.01% 2600

Other funds holding XPH

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
NCM
Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AllianceBernstein's XPH Position: Q2 2014 in Review

AllianceBernstein sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2014, closing a stake of 6,888 shares — an estimated $322K sold.

AllianceBernstein first reported a position in XPH in Q1 2014 and held it in 1 quarter. The position peaked at $322K in Q1 2014. 69 funds tracked by Wall St. Rank hold XPH as of Q2 2014.

  • AllianceBernstein reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2014 after selling out during the quarter.
  • AllianceBernstein sold 6,888 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2014, an estimated $322K.
  • AllianceBernstein first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2014 and held it in 1 quarter.
  • AllianceBernstein's State Street SPDR S&P Pharmaceuticals ETF position peaked at $322K in Q1 2014.
  • 69 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2014.

Based on AllianceBernstein's 13F filing for Q2 2014, filed 13 Aug 2014.